Cinemark Holdings Inc

CNK remains in a secular uptrend but has recently broken below short-term EMAs and is testing the 20-day EMA and 50-day SMA support zone. Medium-term bias is still bullish as price holds above the 50-day and 200-day SMAs despite an active support failure candle. Short-term execution readiness is neutral given mixed signals and no clear oversold bounce. Defer entry until evidence of acceptance off the 20-day EMA or support zone confirms resumption of the advance.

• ↑Q2 2026 revenue reached a record $1B; adjusted EBITDA $294M (27.1% margin)
• ↑Authorized $300M share repurchase and increased quarterly dividend 12.5% to $0.09
• ↓Negative profitability factors signal weak conversion of revenue into earnings